We developed and validated a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to quantify the antimalarials artesunate (ARS) and mefloquine (MFQ) in fixed-dose tablets. The detection was performed by a triple-quadrupole mass spectrometer in multiple reaction monitoring (MRM) in positive ion mode via electrospray ionization. Chromatographic separation was achieved with an XBridge C18 column (50 × 2.1 mm, 5 μm), using isocratic elution (350 μL min -1 ) of water/acetonitrile/methanol (30:35:35, v/v/v) containing 0.1% formic acid. The method was validated according to the International Conference of Harmonization (ICH) guidelines. The calibration curves obtained for ARS (400 to 600 ng mL -1 ) and MFQ (800 to 1200 ng mL -1 ) showed good linearity (r 2 > 0.99), precision (relative standard deviation (RSD): ARS < 2.0%; MFQ < 1.9%), and accuracy (recoveries: ARS, 102.4-103.4%; MFQ, 97.4-101.6%), and were stable for 24 h at 8 °C. The method was successfully applied to commercial tablets, and recoveries of 98.7 ± 4.7% (ARS) and 105.6 ± 3.13% (MFQ). The method developed is a reliable alternative for public quality inspection control with the advantage of tandem mass specificity and speed.
Keywords: antimalarial, artesunate, LC-MS/MS, mefloquine, validation
IntroductionMalaria is an infectious disease caused by protozoan parasites of the genus Plasmodium.1 Several Plasmodium species are known to infect humans, and Plasmodium falciparum is considered the most dangerous species, since it is responsible for the most severe and fatal cases of malaria.2 Malaria is one of the most serious public health concerns worldwide and 3.2 billion people remain at risk of being infected. In 2015, 214 million new cases of malaria and 438,000 deaths were reported. 2 The treatment of malaria is based on targeting the lifecycle of the parasite. The World Health Organization (WHO) recommends artemisinin-based combination therapies (ACTs), such as artesunate (ARS) (C 19 (Figure 1), for the treatment of uncomplicated malaria, caused by P. falciparum.
2,3ACTs combine two active drugs with different mechanisms of action in order to increase the spectrum of activity and effectiveness, and to prevent antimalarial drug resistance. In an ACT, the immediate effect of an artemisinin derivative, which rapidly clears asexual blood-stage parasites and gametocytes, is combined with J. Braz. Chem. Soc. 616 a drug of a different class that has a longer half-life, thus eliminating residual parasites. 4,5 One of the barriers in the fight against malaria is the increasing presence on the market of counterfeit drugs, which, in recent years, has led to the development of P. falciparum resistance to therapy.
Simultaneous Determination of Antimalarial Agents by LC-MS/MS and Its Application6 Antimalarials are among the most widely administered drugs in tropical countries and have been particularly targeted by counterfeiters. The use of counterfeit drugs or substandard antimalarial drugs can cause increased morbidity, adverse effects, and mortal...